首页> 美国卫生研究院文献>AAPS PharmSciTech >In Vitro Evaluation of Proniosomes as a Drug Carrier for Flurbiprofen
【2h】

In Vitro Evaluation of Proniosomes as a Drug Carrier for Flurbiprofen

机译:proniosomes作为氟比洛芬的药物载体的体外评价

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The purpose of the present investigation is to formulate and evaluate proniosomal transdermal carrier systems for flurbiprofen. Proniosomes were prepared using various non-ionic surfactants, namely span 20 (Sp 20), span 40 (Sp 40), span 60 (Sp 60) and span 80 (Sp 80) without and with cholesterol at percentages ranging from 0% to 50%. The effect of surfactant type and cholesterol content on drug release was investigated. Drug release was tested by diffusion through cellophane membrane and rabbit skin. Drug release from the prepared systems was compared to that from flurbiprofen suspensions in distilled water and HPMC (hydroxypropylmethylcellulose) gels. In case of Sp 20 and Sp 80, the added amount of cholesterol affected the preparation type to be either proniosomal alcoholic solutions or liquid crystalline gel systems. On the other hand, both Sp 40 and Sp 60 produced gel systems in presence or absence of cholesterol. Microscopic observations showed that either proniosomal solutions or gel formulations immediately converted to niosomal dispersions upon hydration. Due to the skin permeation barrier, rabbit skin showed lower drug diffusion rates compared to cellophane membrane. The proniosomal composition controlled drug diffusion rates to be either faster or slower than the prepared flurbiprofen suspensions in HPMC gels or distilled water, respectively. In conclusion, this study demonstrated the possibility of using proniosomal formulations for transdermal drug delivery.
机译:本研究的目的是制定和评估氟比洛芬的前体透皮载体系统。使用各种非离子表面活性剂制备前体体,即跨度20(Sp 20),跨度40(Sp 40),跨度60(Sp 60)和跨度80(Sp 80)不含和含胆固醇的百分比范围为0%至50 %。研究了表面活性剂类型和胆固醇含量对药物释放的影响。通过玻璃纸膜和兔皮肤的扩散来测试药物的释放。将制备的系统中的药物释放与氟比洛芬悬浮液在蒸馏水和HPMC(羟丙基甲基纤维素)凝胶中的释放进行了比较。在Sp 20和Sp 80的情况下,胆固醇的添加量会影响制剂类型,无论是原液乙醇溶液还是液晶凝胶系统。另一方面,在存在或不存在胆固醇的情况下,Sp 40和Sp 60都能产生凝胶体系。显微镜观察表明,原代溶液或凝胶制剂在水合后立即转变为纳米分散体。由于皮肤渗透屏障,与玻璃纸膜相比,兔皮肤的药物扩散速率较低。与在HPMC凝胶或蒸馏水中制备的氟比洛芬混悬液相比,后代组合物控制药物的扩散速率更快或更慢。总而言之,这项研究证明了使用前胎体制剂进行透皮给药的可能性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号